Circulation, Vol 86, 798-802, Copyright © 1992 by American Heart Association
S Ghio, S de Servi, R Perotti, E Eleuteri, C Montemartini and G Specchia
BACKGROUND. Tolerance to the effects of organic nitrates develops rapidly
during continuous exposure to these drugs; its main mechanism seems to be
an intracellular sulfhydryl group depletion. However, the relative
susceptibility to the development of nitroglycerin tolerance of the
arterial or venous circulation in humans is still a matter of dispute.
METHODS AND RESULTS. Twenty patients with coronary artery disease underwent
a continuous 24-hour nitroglycerin infusion followed by a bolus
administration of N-acetylcysteine. Forearm blood flow (ml/100 ml/min) and
venous volume (ml/100 ml) were measured by strain gauge plethysmography
under control conditions, at the end of nitroglycerin titration, after
24-hour infusion, and after N- acetylcysteine; vascular resistance was
calculated as mean cuff blood pressure divided by flow. After 24 hours of
nitroglycerin infusion, the initial increase in venous volume was reduced
48% (p less than 0.01), whereas the acute effects on vascular resistance
were not attenuated in the whole group. N-Acetylcysteine completely
restored nitroglycerin venodilator effects in all 10 patients in whom
attenuation of the venous effects was observed during the infusion period.
CONCLUSIONS. The data indicate that the susceptibility to the development
of nitrate tolerance in humans is higher in the venous than in the arterial
circulation, and that the sulfhydryl group donor N-acetylcysteine is
extremely effective in reversing nitroglycerin tolerance in the venous
circulation in humans.
ARTICLES
Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans. Effects of N- acetylcysteine administration
Division of Cardiology, IRCCS S. Matteo Hospital, Pavia, Italy.
This article has been cited by other articles:
![]() |
J. D. MacPherson, T. D. Gillespie, H. A. Dunkerley, D. H. Maurice, and B. M. Bennett Inhibition of Phosphodiesterase 5 Selectively Reverses Nitrate Tolerance in the Venous Circulation J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Thadani Nitrate Therapy and the Development of Tolerance Arch Fam Med, August 1, 1993; 2(8): 880 - 885. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |